36 results
8-K
EX-99.1
IRME
IR-Med Inc.
10 Sep 24
Other Events
4:05pm
, which are not historical in nature, are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation … product liability or other adverse litigation, commercialization and technological difficulties, and the other risks identified in our most recent annual
8-K
EX-99.1
IRME
IR-Med Inc.
28 Aug 24
IR-MED Appoints Ran Ziskind, Tech Entrepreneur, Growth Manager, and Inventor as Chief Executive Officer
4:05pm
-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. For example, IR-Med is using … acceptance of our products in the market, the introduction of competitive products, the impact of any product liability or other adverse litigation
8-K
EX-99.1
sb2yy8b5pgp3vi
5 Apr 24
IR-MED’s PressureSafe™ Receives FDA Listing for the Indication of Decision Support Device for Pressure Injuries
9:15am
8-K
EX-99.1
68c8e5jgul9n3gu827l
4 Oct 23
IR-MED Appoints Healthcare Executive and Entrepreneur Tzur Di-Cori as Chief Executive Officer
5:00pm
8-K
EX-99.1
rqxmsnjs7rdbc
26 Sep 23
IR-MED to Conduct Usability Study with Methodist Healthcare of San Antonio for its PressureSafe Device Which is Slated for U.S. Launch in H1 2024
9:15am
8-K
EX-99.1
yw7b3n7s
21 Aug 23
IR-MED Chairman & Interim CEO Issues Letter to Shareholders
9:00am
DEF 14A
2882ky3bkn0ffda5duw
28 Nov 22
Definitive proxy
12:36pm